Yahoo · Sep 8, 2026
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
NASDAQ · XRAY
DENTSPLY SIRONA Inc.
Healthcare · Medical - Instruments & Supplies
$9.83
Up+$0.28 (+2.85%)
Updated Sep 16, 2026, 4:26 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.31B
- P/E ratio
- -2.62
- Dividend yield
- 6.51%
- 52-week range
- $9.41 – $14.76
- Volume
- 4.92M
- Avg. volume
- 3.53M
Price performance
XRAY price history
1M range · 20 trading sessions · Daily adjusted prices
XRAY closed at $9.83 after 20 trading sessions, down 11.52% for the selected period.
- Last close
- $9.83
- Period change
- -11.52%
- Period low
- $9.83
- Period high
- $11.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.28 | $10.385 | $9.81 | $9.83 | 4.92M |
| Sep 14, 2026 | $10.47 | $10.6165 | $10.345 | $10.38 | 3.21M |
| Sep 11, 2026 | $10.67 | $10.72 | $10.28 | $10.46 | 3.25M |
| Sep 10, 2026 | $10.65 | $10.65 | $10.39 | $10.50 | 3.45M |
| Sep 9, 2026 | $10.89 | $10.94 | $10.63 | $10.72 | 3.23M |
| Sep 8, 2026 | $11.24 | $11.28 | $10.935 | $10.99 | 3.16M |
| Sep 4, 2026 | $11.29 | $11.53 | $11.195 | $11.38 | 2.6M |
| Sep 3, 2026 | $11.51 | $11.715 | $11.13 | $11.43 | 3.93M |
| Sep 2, 2026 | $10.89 | $11.55 | $10.83 | $11.29 | 4.61M |
| Sep 1, 2026 | $11.16 | $11.26 | $10.735 | $10.76 | 3.58M |
| Aug 31, 2026 | $11.185 | $11.225 | $10.89 | $11.17 | 4.43M |
| Aug 28, 2026 | $11.165 | $11.29 | $11.05 | $11.12 | 2.97M |
| Aug 27, 2026 | $10.80 | $11.26 | $10.80 | $11.04 | 3.56M |
| Aug 26, 2026 | $10.97 | $11.09 | $10.87 | $10.93 | 2.88M |
| Aug 25, 2026 | $10.81 | $10.99 | $10.605 | $10.97 | 3.11M |
| Aug 24, 2026 | $11.11 | $11.235 | $10.845 | $10.89 | 2.9M |
| Aug 21, 2026 | $10.845 | $11.0988 | $10.81 | $10.92 | 3.31M |
| Aug 20, 2026 | $11.05 | $11.15 | $10.75 | $10.78 | 3.47M |
| Aug 19, 2026 | $11.31 | $11.55 | $11.025 | $11.03 | 3.86M |
| Aug 18, 2026 | $11.24 | $11.41 | $11.08 | $11.11 | 4.07M |
Latest XRAY news
The latest Smart Investors Daily articles mentioning XRAY.
Stock researchCompany · Overview
XRAY research
Overview
Company profile and research snapshot.
Company profile
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $15.33
- Implied upside
- —
- Analysts
- 21
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Barclays | Underweight | — |
| Jul 29, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 4, 2026 | Barclays | Underweight | — |
| May 7, 2026 | UBS | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 4, 2026
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation
DENTSPLY SIRONA (XRAY) shares are in focus after the company reported second quarter 2026 results that returned the business to profitability while net sales declined 4.1% year over year. The latest results and upcoming appearance at the Baird 2026 Global Healthcare Conference come after a mixed share price pattern for DENTSPLY SIRONA, with a 7 day share price return of 3.53% but a 30 day share price return that declined 19.90%. Recent momentum has been choppy, as a 90 day share price return...
Yahoo · Sep 4, 2026
Dentsply Sirona (XRAY) Stock May Still Trade At A Discount
DENTSPLY SIRONA stock has had a difficult run over the past few years, yet on broad valuation checks it now screens as one of the cheaper options in its peer group. The share price history and the current multiples are sending very different signals about what the market expects from the business. Over the past 5 years, DENTSPLY SIRONA shareholders have seen the stock fall about 79.6%, which points to a long period of weak sentiment that still weighs on expectations today. The valuation...
Yahoo · Sep 4, 2026
Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis?
Dentsply Sirona recently reported second-quarter 2026 results showing a 4.1% year-over-year net sales decline but a return to net income, with higher margins and stronger cash generation, and also confirmed it will present at the Baird 2026 Global Healthcare Conference on September 15, 2026. The combination of improved profitability and cash flow, despite weaker revenue and a history of pressure on returns, led management to reiterate full-year 2026 guidance, highlighting a sharper focus on...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
